1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 04 JANUARY 2016

Cancer Drug News 04 JANUARY 2016

  • January 2016
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - 2016 Global Oncology Pipeline To Benefit From Breaking Innovation Barriers
Industry Trend Analysis - Adcetris To Maintain Lymphoma Market Position
Industry Brief - EMA Validates Qinprezo MAA For r/r AML
Industry Brief - Sun Gains US Imatinib Approval
Industry Brief - Revlimid Granted Japanese Expanded Approval In Multiple Myeloma
Industry Brief - OXiGENE's OXi4503 Gains EU Orphan Designation For AML
Industry Brief - Foundation Medicine/Mirati To Co-Develop Glesatinib Companion Diagnostic
Industry Brief - Merrimack Amends MM-121 Phase II NSCLC Study
Industry Brief - BI's 3rd-Generation EGFR TKI Receives Breakthrough Designation In Lung Cancer
Industry Brief - Tagrisso In NSCLC Subpopulation Recommended For EC Approval
Industry Brief - Opdivo Approved For NSCLC In Japan
Industry Brief - Exelixis Completes NDA Submission For Cabozantinib In RCC
Industry Brief - AVEO/EUSA Sign Tivozanib Licensing Deal In Europe
Industry Brief - Merck/Pfizer Advance Avelumab Development
Industry Brief - Janssen Inks Cancer-Focused Pact With Bavarian Nordic
Industry Brief - Merck/Pfizer/Syndax Collaborate On Avelumab/Entinostat Combination In OC
Industry Brief - FDA Approves Expanded Indication Keytruda In Melanoma
Industry Brief - EC Approves Amgen's Imlygic As First Oncolytic Immunotherapy
Industry Brief - Array's Binimetinib Phase III Trial Meets Primary Endpoint For NRAS-Mutant Melanoma
Industry Brief - Agenus Acquires PhosImmune
Industry Brief - Sunshine Acquires All Remaining Worldwide Patents For Adva-27a
Industry Brief - Celgene Settles Lenalidomide Patent Litigation
Industry Trend Analysis - Rising Cancer Prevalence To Buoy Pharmaceutical Demand
Industry Brief - Cellectar/Pierre Sign Oncology Research Collaboration
Industry Brief - BI Invests In Biopharmaceutical Production Facility In Vienna
Industry Brief - Merrimack Raises Funds Through Private Placement
Industry Brief - Amgen Acquires Medigene Spin-Off
Industry Brief - AstraZeneca Invests In Novel Cancer Opportunity
Industry Brief - Cancer Conferences - March 2016

Table Of Contents

Cancer Drug News 04 JANUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Lung Cancer Surgery Market by Procedure, Minimally Invasive, Device, Monitoring, Endoscopic Instrument - Global Forecast to 2021

Lung Cancer Surgery Market by Procedure, Minimally Invasive, Device, Monitoring, Endoscopic Instrument - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The global lung cancer surgery market is segmented based ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.